APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nocturia

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nocturia Industry Growth and Trends Forecast to 2032

28 December 2025121 pages

Choose your research edition.

Industry ResearchNocturia Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Nocturia Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Nocturia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nocturia Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Nocturia Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

According to APO Research, the global Nocturia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nocturia market include Abbott, Allergan, APOTEX INC, Astellas Pharma, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Ferring Pharmaceuticals and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nocturia market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nocturia market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nocturia market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nocturia.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nocturia market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nocturia Market by Company

Abbott

Allergan

APOTEX INC

Astellas Pharma

Astra Zeneca

Bristol-Myers Squibb

Eli Lilly

Ferring Pharmaceuticals

GlaxoSmithKline

Johnson & Johnson

Merck

Mylan

Novartis

Pfizer

Rechon Life Science AB

Sagent Pharmaceuticals

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva

Chengdu Leer Pharmaceutical

Fosun Pharma

Hainan Zhonghe Pharmaceutical

Nanjing Xingyin Pharmaceutical Group

Hybio Pharmaceutical

Zhejiang Conba Pharmaceutical

Nocturia Segment by Type

Desmopressin

Diuretics

Anticholinergic Drugs

Alpha Blockers

Others

Nocturia Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Nocturia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nocturia companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nocturia Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nocturia Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nocturia Market Share by Region (2021-2026) Table 4. Global Nocturia Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nocturia Market Share by Region (2027-2032) Table 6. Global Nocturia Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nocturia Market Size Share by Type (2021-2026) Table 9. Global Nocturia Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nocturia Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nocturia Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nocturia Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nocturia Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nocturia Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nocturia Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nocturia Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nocturia Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nocturia Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nocturia Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nocturia Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nocturia Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nocturia Market Size Share by Application (2021-2026) Table 24. Global Nocturia Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nocturia Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nocturia Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nocturia Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nocturia Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nocturia Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nocturia Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nocturia Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nocturia Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nocturia Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nocturia Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nocturia Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nocturia Industry Trends Table 37. Nocturia Industry Drivers Table 38. Nocturia Industry Opportunities and Challenges Table 39. Nocturia Industry Restraints Table 40. Global Nocturia Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nocturia Revenue Market Share by Company (2021-2026) Table 42. Global Nocturia Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nocturia Key Company Headquarters & Area Served Table 44. Global Nocturia Company, Product Type & Application Table 45. Global Nocturia Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nocturia by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Nocturia Product Portfolio Table 52. Abbott Recent Development Table 53. Allergan Company Information Table 54. Allergan Business Overview Table 55. Allergan Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Allergan Nocturia Product Portfolio Table 57. Allergan Recent Development Table 58. APOTEX INC Company Information Table 59. APOTEX INC Business Overview Table 60. APOTEX INC Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. APOTEX INC Nocturia Product Portfolio Table 62. APOTEX INC Recent Development Table 63. Astellas Pharma Company Information Table 64. Astellas Pharma Business Overview Table 65. Astellas Pharma Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Astellas Pharma Nocturia Product Portfolio Table 67. Astellas Pharma Recent Development Table 68. Astra Zeneca Company Information Table 69. Astra Zeneca Business Overview Table 70. Astra Zeneca Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Astra Zeneca Nocturia Product Portfolio Table 72. Astra Zeneca Recent Development Table 73. Bristol-Myers Squibb Company Information Table 74. Bristol-Myers Squibb Business Overview Table 75. Bristol-Myers Squibb Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bristol-Myers Squibb Nocturia Product Portfolio Table 77. Bristol-Myers Squibb Recent Development Table 78. Eli Lilly Company Information Table 79. Eli Lilly Business Overview Table 80. Eli Lilly Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Eli Lilly Nocturia Product Portfolio Table 82. Eli Lilly Recent Development Table 83. Ferring Pharmaceuticals Company Information Table 84. Ferring Pharmaceuticals Business Overview Table 85. Ferring Pharmaceuticals Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ferring Pharmaceuticals Nocturia Product Portfolio Table 87. Ferring Pharmaceuticals Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Nocturia Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Johnson & Johnson Company Information Table 94. Johnson & Johnson Business Overview Table 95. Johnson & Johnson Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Johnson & Johnson Nocturia Product Portfolio Table 97. Johnson & Johnson Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Merck Nocturia Product Portfolio Table 102. Merck Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Mylan Nocturia Product Portfolio Table 107. Mylan Recent Development Table 108. Novartis Company Information Table 109. Novartis Business Overview Table 110. Novartis Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Novartis Nocturia Product Portfolio Table 112. Novartis Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Pfizer Nocturia Product Portfolio Table 117. Pfizer Recent Development Table 118. Rechon Life Science AB Company Information Table 119. Rechon Life Science AB Business Overview Table 120. Rechon Life Science AB Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Rechon Life Science AB Nocturia Product Portfolio Table 122. Rechon Life Science AB Recent Development Table 123. Sagent Pharmaceuticals Company Information Table 124. Sagent Pharmaceuticals Business Overview Table 125. Sagent Pharmaceuticals Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Sagent Pharmaceuticals Nocturia Product Portfolio Table 127. Sagent Pharmaceuticals Recent Development Table 128. Sanofi Company Information Table 129. Sanofi Business Overview Table 130. Sanofi Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Sanofi Nocturia Product Portfolio Table 132. Sanofi Recent Development Table 133. Sun Pharmaceutical Industries Ltd. Company Information Table 134. Sun Pharmaceutical Industries Ltd. Business Overview Table 135. Sun Pharmaceutical Industries Ltd. Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Sun Pharmaceutical Industries Ltd. Nocturia Product Portfolio Table 137. Sun Pharmaceutical Industries Ltd. Recent Development Table 138. Teva Company Information Table 139. Teva Business Overview Table 140. Teva Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Teva Nocturia Product Portfolio Table 142. Teva Recent Development Table 143. Chengdu Leer Pharmaceutical Company Information Table 144. Chengdu Leer Pharmaceutical Business Overview Table 145. Chengdu Leer Pharmaceutical Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Chengdu Leer Pharmaceutical Nocturia Product Portfolio Table 147. Chengdu Leer Pharmaceutical Recent Development Table 148. Fosun Pharma Company Information Table 149. Fosun Pharma Business Overview Table 150. Fosun Pharma Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Fosun Pharma Nocturia Product Portfolio Table 152. Fosun Pharma Recent Development Table 153. Hainan Zhonghe Pharmaceutical Company Information Table 154. Hainan Zhonghe Pharmaceutical Business Overview Table 155. Hainan Zhonghe Pharmaceutical Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Hainan Zhonghe Pharmaceutical Nocturia Product Portfolio Table 157. Hainan Zhonghe Pharmaceutical Recent Development Table 158. Nanjing Xingyin Pharmaceutical Group Company Information Table 159. Nanjing Xingyin Pharmaceutical Group Business Overview Table 160. Nanjing Xingyin Pharmaceutical Group Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Nanjing Xingyin Pharmaceutical Group Nocturia Product Portfolio Table 162. Nanjing Xingyin Pharmaceutical Group Recent Development Table 163. Hybio Pharmaceutical Company Information Table 164. Hybio Pharmaceutical Business Overview Table 165. Hybio Pharmaceutical Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Hybio Pharmaceutical Nocturia Product Portfolio Table 167. Hybio Pharmaceutical Recent Development Table 168. Zhejiang Conba Pharmaceutical Company Information Table 169. Zhejiang Conba Pharmaceutical Business Overview Table 170. Zhejiang Conba Pharmaceutical Nocturia Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Zhejiang Conba Pharmaceutical Nocturia Product Portfolio Table 172. Zhejiang Conba Pharmaceutical Recent Development Table 173. North America Nocturia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Nocturia Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Nocturia Market Share by Country (2021-2026) Table 176. North America Nocturia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Nocturia Market Share Forecast by Country (2027-2032) Table 178. Europe Nocturia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Nocturia Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Nocturia Market Share by Country (2021-2026) Table 181. Europe Nocturia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Nocturia Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Nocturia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Nocturia Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Nocturia Market Share by Country (2021-2026) Table 186. Asia-Pacific Nocturia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Nocturia Market Share Forecast by Country (2027-2032) Table 188. Latin America Nocturia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Nocturia Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Nocturia Market Share by Country (2021-2026) Table 191. Latin America Nocturia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Nocturia Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa Nocturia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa Nocturia Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa Nocturia Market Share by Country (2021-2026) Table 196. Middle East & Africa Nocturia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa Nocturia Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nocturia Product Image Figure 3. Global Nocturia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nocturia Market Size (2021-2032) & (US$ Million) Figure 5. Global Nocturia Market Share by Region: 2025 VS 2032 Figure 6. Global Nocturia Market Share by Region (2021-2032) Figure 7. North America Nocturia Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nocturia Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nocturia Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nocturia Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nocturia Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Desmopressin Image Figure 13. Global Desmopressin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Diuretics Image Figure 15. Global Diuretics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Anticholinergic Drugs Image Figure 17. Global Anticholinergic Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Alpha Blockers Image Figure 19. Global Alpha Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Nocturia Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Nocturia Market Share by Type 2025 VS 2032 Figure 24. North America Nocturia Market Size Share by Type (2021-2032) Figure 25. Europe Nocturia Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Nocturia Market Size Share by Type (2021-2032) Figure 27. Latin America Nocturia Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Nocturia Market Size Share by Type (2021-2032) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Nocturia Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nocturia Market Share by Application 2025 VS 2032 Figure 37. North America Nocturia Market Size Share by Application (2021-2032) Figure 38. Europe Nocturia Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Nocturia Market Size Share by Application (2021-2032) Figure 40. Latin America Nocturia Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Nocturia Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Nocturia Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Nocturia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Nocturia Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Nocturia Market Share by Country (2021-2032) Figure 47. Europe Nocturia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nocturia Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nocturia Market Share by Country (2021-2032) Figure 50. Asia-Pacific Nocturia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Nocturia Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Nocturia Market Share by Country (2021-2032) Figure 53. Latin America Nocturia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nocturia Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nocturia Market Share by Country (2021-2032) Figure 56. Middle East & Africa Nocturia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Nocturia Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Nocturia Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Desmopressin
  • Diuretics
  • Anticholinergic Drugs
  • Alpha Blockers
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Abbott
  • Allergan
  • APOTEX INC
  • Astellas Pharma
  • Astra Zeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • Ferring Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Mylan
  • Novartis
  • Pfizer
  • Rechon Life Science AB
  • Sagent Pharmaceuticals
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva
  • Chengdu Leer Pharmaceutical
  • Fosun Pharma
  • Hainan Zhonghe Pharmaceutical
  • Nanjing Xingyin Pharmaceutical Group
  • Hybio Pharmaceutical
  • Zhejiang Conba Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nocturia Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nocturia Market Size by Region (2021-2032)
  5. 1.4.1 Global Nocturia Market Size by Region (2021-2026)
  6. 1.4.2 Global Nocturia Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nocturia Market Size (2021-2032)
  8. 1.5.1 North America Nocturia Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nocturia Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nocturia Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nocturia Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nocturia Market Size Growth Rate (2021-2032)
2 Nocturia Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Desmopressin
  3. 2.1.2 Diuretics
  4. 2.1.3 Anticholinergic Drugs
  5. 2.1.4 Alpha Blockers
  6. 2.1.5 Others
  7. 2.2 Global Nocturia Market Size by Type
  8. 2.2.1 Global Nocturia Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Nocturia Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Nocturia Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Nocturia Market Size by Regions
  12. 2.3.1 North America Nocturia Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Nocturia Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Nocturia Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Nocturia Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Nocturia Market Size Breakdown by Type (2021-2026)
3 Nocturia Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Hospital Pharmacies
  5. 3.2 Global Nocturia Market Size by Application
  6. 3.2.1 Global Nocturia Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Nocturia Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Nocturia Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Nocturia Market Size by Regions
  10. 3.3.1 North America Nocturia Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Nocturia Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Nocturia Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Nocturia Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Nocturia Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nocturia Industry Trends
  2. 4.2 Nocturia Industry Drivers
  3. 4.3 Nocturia Industry Opportunities and Challenges
  4. 4.4 Nocturia Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nocturia Revenue (2021-2026)
  2. 5.2 Global Nocturia Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nocturia Key Company Headquarters & Area Served
  4. 5.4 Global Nocturia Company, Product Type & Application
  5. 5.5 Global Nocturia Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nocturia Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nocturia Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nocturia Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Nocturia Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Nocturia Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 APOTEX INC
  14. 6.3.1 APOTEX INC Company Information
  15. 6.3.2 APOTEX INC Business Overview
  16. 6.3.3 APOTEX INC Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 APOTEX INC Nocturia Product Portfolio
  18. 6.3.5 APOTEX INC Recent Developments
  19. 6.4 Astellas Pharma
  20. 6.4.1 Astellas Pharma Company Information
  21. 6.4.2 Astellas Pharma Business Overview
  22. 6.4.3 Astellas Pharma Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Astellas Pharma Nocturia Product Portfolio
  24. 6.4.5 Astellas Pharma Recent Developments
  25. 6.5 Astra Zeneca
  26. 6.5.1 Astra Zeneca Company Information
  27. 6.5.2 Astra Zeneca Business Overview
  28. 6.5.3 Astra Zeneca Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Astra Zeneca Nocturia Product Portfolio
  30. 6.5.5 Astra Zeneca Recent Developments
  31. 6.6 Bristol-Myers Squibb
  32. 6.6.1 Bristol-Myers Squibb Company Information
  33. 6.6.2 Bristol-Myers Squibb Business Overview
  34. 6.6.3 Bristol-Myers Squibb Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb Nocturia Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Nocturia Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Ferring Pharmaceuticals
  44. 6.8.1 Ferring Pharmaceuticals Company Information
  45. 6.8.2 Ferring Pharmaceuticals Business Overview
  46. 6.8.3 Ferring Pharmaceuticals Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ferring Pharmaceuticals Nocturia Product Portfolio
  48. 6.8.5 Ferring Pharmaceuticals Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline Nocturia Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Johnson & Johnson
  56. 6.10.1 Johnson & Johnson Company Information
  57. 6.10.2 Johnson & Johnson Business Overview
  58. 6.10.3 Johnson & Johnson Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Johnson & Johnson Nocturia Product Portfolio
  60. 6.10.5 Johnson & Johnson Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Merck Nocturia Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Mylan Nocturia Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Novartis
  74. 6.13.1 Novartis Company Information
  75. 6.13.2 Novartis Business Overview
  76. 6.13.3 Novartis Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Novartis Nocturia Product Portfolio
  78. 6.13.5 Novartis Recent Developments
  79. 6.14 Pfizer
  80. 6.14.1 Pfizer Company Information
  81. 6.14.2 Pfizer Business Overview
  82. 6.14.3 Pfizer Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Pfizer Nocturia Product Portfolio
  84. 6.14.5 Pfizer Recent Developments
  85. 6.15 Rechon Life Science AB
  86. 6.15.1 Rechon Life Science AB Company Information
  87. 6.15.2 Rechon Life Science AB Business Overview
  88. 6.15.3 Rechon Life Science AB Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Rechon Life Science AB Nocturia Product Portfolio
  90. 6.15.5 Rechon Life Science AB Recent Developments
  91. 6.16 Sagent Pharmaceuticals
  92. 6.16.1 Sagent Pharmaceuticals Company Information
  93. 6.16.2 Sagent Pharmaceuticals Business Overview
  94. 6.16.3 Sagent Pharmaceuticals Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Sagent Pharmaceuticals Nocturia Product Portfolio
  96. 6.16.5 Sagent Pharmaceuticals Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Sanofi Nocturia Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Sun Pharmaceutical Industries Ltd.
  104. 6.18.1 Sun Pharmaceutical Industries Ltd. Company Information
  105. 6.18.2 Sun Pharmaceutical Industries Ltd. Business Overview
  106. 6.18.3 Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Sun Pharmaceutical Industries Ltd. Nocturia Product Portfolio
  108. 6.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  109. 6.19 Teva
  110. 6.19.1 Teva Company Information
  111. 6.19.2 Teva Business Overview
  112. 6.19.3 Teva Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Teva Nocturia Product Portfolio
  114. 6.19.5 Teva Recent Developments
  115. 6.20 Chengdu Leer Pharmaceutical
  116. 6.20.1 Chengdu Leer Pharmaceutical Company Information
  117. 6.20.2 Chengdu Leer Pharmaceutical Business Overview
  118. 6.20.3 Chengdu Leer Pharmaceutical Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Chengdu Leer Pharmaceutical Nocturia Product Portfolio
  120. 6.20.5 Chengdu Leer Pharmaceutical Recent Developments
  121. 6.21 Fosun Pharma
  122. 6.21.1 Fosun Pharma Company Information
  123. 6.21.2 Fosun Pharma Business Overview
  124. 6.21.3 Fosun Pharma Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Fosun Pharma Nocturia Product Portfolio
  126. 6.21.5 Fosun Pharma Recent Developments
  127. 6.22 Hainan Zhonghe Pharmaceutical
  128. 6.22.1 Hainan Zhonghe Pharmaceutical Company Information
  129. 6.22.2 Hainan Zhonghe Pharmaceutical Business Overview
  130. 6.22.3 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Hainan Zhonghe Pharmaceutical Nocturia Product Portfolio
  132. 6.22.5 Hainan Zhonghe Pharmaceutical Recent Developments
  133. 6.23 Nanjing Xingyin Pharmaceutical Group
  134. 6.23.1 Nanjing Xingyin Pharmaceutical Group Company Information
  135. 6.23.2 Nanjing Xingyin Pharmaceutical Group Business Overview
  136. 6.23.3 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Nanjing Xingyin Pharmaceutical Group Nocturia Product Portfolio
  138. 6.23.5 Nanjing Xingyin Pharmaceutical Group Recent Developments
  139. 6.24 Hybio Pharmaceutical
  140. 6.24.1 Hybio Pharmaceutical Company Information
  141. 6.24.2 Hybio Pharmaceutical Business Overview
  142. 6.24.3 Hybio Pharmaceutical Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Hybio Pharmaceutical Nocturia Product Portfolio
  144. 6.24.5 Hybio Pharmaceutical Recent Developments
  145. 6.25 Zhejiang Conba Pharmaceutical
  146. 6.25.1 Zhejiang Conba Pharmaceutical Company Information
  147. 6.25.2 Zhejiang Conba Pharmaceutical Business Overview
  148. 6.25.3 Zhejiang Conba Pharmaceutical Nocturia Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Zhejiang Conba Pharmaceutical Nocturia Product Portfolio
  150. 6.25.5 Zhejiang Conba Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Nocturia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nocturia Market Size by Country (2021-2026)
  3. 7.3 North America Nocturia Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nocturia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nocturia Market Size by Country (2021-2026)
  3. 8.3 Europe Nocturia Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nocturia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nocturia Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nocturia Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nocturia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nocturia Market Size by Country (2021-2026)
  3. 10.3 South America Nocturia Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nocturia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nocturia Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nocturia Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst